- Published on: January 27, 2022
- 00:30
Havana, Jan 27 (Prensa Latina) Nasalferon, a medicine developed by Cuba's Center for Genetic Engineering and Biotechnology (CIGB) and currently used to treat Covid-19 could be used against different acute respiratory conditions, an authorized source reported.